What are the best treatments for Cardiomyopathy?

Treatments for Cardiomyopathy are highly personalized and focus on managing symptoms, preventing complications like heart failure, and addressing the underlying cause of the heart muscle dysfunction. Standard care typically involves a combination of life-long medication, lifestyle modifications, and, in some cases, surgical interventions or implantable devices tailored to the specific type of Cardiomyopathy a patient has.

What are the primary medical treatments for Cardiomyopathy?

Management of Cardiomyopathy begins with medication aimed at improving the heart's pumping efficiency and reducing the workload on the heart muscle. While treatment plans vary based on whether a patient has dilated, hypertrophic, or restrictive Cardiomyopathy, physicians often prescribe common classes of medication to stabilize cardiac function:

• Beta-blockers (e.g., metoprolol, carvedilol) to slow the heart rate and lower blood pressure.


• ACE inhibitors (e.g., lisinopril, enalapril) or ARBs (e.g., losartan, valsartan) to relax blood vessels and improve blood flow.


• Diuretics (e.g., furosemide) to reduce fluid buildup in the lungs and extremities.


• Mineralocorticoid receptor antagonists (e.g., spironolactone) to prevent further heart muscle scarring.


• Anticoagulants (e.g., warfarin, apixaban) for patients at high risk of blood clots.

What non-pharmacological and surgical options exist?

When medications are insufficient, interventional or surgical procedures may be necessary to treat Cardiomyopathy. Implantable cardioverter-defibrillators (ICDs) are frequently used to prevent sudden cardiac death in patients prone to dangerous arrhythmias. For those with obstructive hypertrophic Cardiomyopathy, a septal myectomy—the surgical removal of a portion of the thickened heart muscle—may be performed. In advanced cases where the heart is severely damaged, cardiac resynchronization therapy (CRT) or even a heart transplant may be considered as a life-saving intervention.

How does the care team approach treatment?

Because Cardiomyopathy is a complex, systemic condition, it requires a multidisciplinary care team. A patient's core team should ideally include a cardiologist specializing in heart failure or electrophysiology, a cardiac surgeon, and a genetic counselor if an inherited form of the disease is suspected. At DiseaseMaps.org, 256 community members have shared their experiences, highlighting the importance of working with specialized pharmacists and physical therapists to safely incorporate cardiac rehabilitation into daily life to improve functional capacity.

Are there emerging treatments and clinical trials?

The field of cardiology is rapidly evolving with new therapies. Recent advancements include targeted pharmacotherapies, such as cardiac myosin inhibitors (e.g., mavacamten), which are specifically designed to treat symptomatic obstructive hypertrophic Cardiomyopathy by addressing the underlying molecular mechanism of muscle contraction. Clinical trials are currently investigating gene therapies and regenerative medicine approaches that aim to repair or replace damaged heart tissue, offering hope for more precise interventions in the future.

Next steps

• Consult a board-certified cardiologist specializing in heart failure to discuss your specific subtype of the disease.


• Work with a genetic counselor to determine if your Cardiomyopathy has a hereditary component that affects family members.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding treatment management.


• Ask your physician about clinical trials at NIH-affiliated centers if current treatments are not providing adequate symptom relief.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your own healthcare team for personalized diagnosis and treatment decisions.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Cardiomyopathy Overview.


• Orphanet: Rare Cardiomyopathies Portal.


• American Heart Association (AHA): Treatment Guidelines for Cardiomyopathy.


• OMIM (Online Mendelian Inheritance in Man): Genetic basis of familial cardiomyopathies.